According to the agreement, Sanyou Bio will upgrade the development process through automation, substantially reducing the R&D timeline for innovative drugs. Through this strategic cooperation, Sanyou ...

Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central ...

Bio-Techne ( ($TECH) ) just unveiled an announcement. At its annual meeting, Bio-Techne Corporation announced the election of nine directors and ...

The LDI-G2 Series represents the next generation of 89 North’s flagship Laser Diode Illuminator platform, providing researchers with higher power density, exceptional illumination stability, and more ...

Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of the ProximityScope™ assay, a groundbreaking spatial ...

CTK Bio received Best in Tech – Technology of the Year for its proprietary compounding platform that converts upcycled plant waste such as hemp, lignin, sawdust, and agave into high-performance ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Bio-Techne (($TECH)) has held its Q1 earnings call. Read on for the main highlights of the call. Bio-Techne’s earnings call presented a mixed ...

Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2025. At this time, all participants have been placed in listen-only mode and the call will be ...

Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment ...

What Happened: A notable Form 4 filing on Monday with the U.S. Securities and Exchange Commission revealed that Keegan, Board Member at Bio-Techne, exercised stock options for 0 shares of TECH, ...